HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transjugular intrahepatic portosystemic shunt in adult liver recipient with delayed graft function.

AbstractBACKGROUND:
Transjugular intrahepatic portosystemic shunt (TIPS) has become an effective treatment for the complications of portal hypertension. We assessed the feasibility and outcome of TIPS in liver transplant recipients who developed delayed graft function (DGF) with portal hypertension.
METHODS:
From June 2003 to June 2004, 80 cadaveric orthotopic liver transplantation (OLTx) have been performed at our institution. Five patients (6.25%) developed DGF with hyperbilirubinemia and ascites with severe portal hypertension and were treated with TIPS placement (in the 6-month time period from the transplantation).
RESULTS:
There were no complications related to the procedure. No episodes of encephalopathy were seen. Four patients had better control of the ascites. In one case, we observed complete recovery of the transplanted liver with normalization of the liver function test. Three patients underwent retransplantation (within 7 days from the TIPS), whereas 1 is still on the list 6 months after TIPS placement with recurrent episodes of ascites.
CONCLUSIONS:
In our preliminary series, TIPS reduced dramatically the portosystemic gradient and improved clinical conditions. The results were negatively affected by the fact that the transplanted liver did not recover its function.
AuthorsF Vasta, A Luca, R Miraglia, M Spada, S Gruttadauria, R Verzaro, D Cintorino, L Mandala, A Arcadipane, G Vizzini, B Gridelli
JournalTransplantation proceedings (Transplant Proc) 2005 Jul-Aug Vol. 37 Issue 6 Pg. 2626-8 ISSN: 0041-1345 [Print] United States
PMID16182767 (Publication Type: Journal Article)
Topics
  • Adult
  • Cadaver
  • Humans
  • Hyperbilirubinemia (epidemiology, surgery)
  • Hypertension, Portal (epidemiology, surgery)
  • Jugular Veins
  • Liver Transplantation (methods, physiology)
  • Portasystemic Shunt, Surgical (methods)
  • Postoperative Complications (classification, surgery)
  • Retrospective Studies
  • Tissue Donors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: